The Zambia Medicines and Medical Supplies Agency, ZAMMSA, has come under intensified scrutiny following the arrest of former director Victor Nyasulu and two others, placing the institution at the centre of a widening accountability discussion within the health sector.
The arrests form part of ongoing investigations into ZAMMSA’s operations, bringing renewed focus to procurement systems, internal controls and overall governance. The development has triggered calls for a broader review, with stakeholders arguing that the concerns raised go beyond individual conduct and point to deeper institutional challenges.
A church body has called for the establishment of a commission of inquiry into ZAMMSA, maintaining that a comprehensive assessment is necessary to restore confidence and ensure transparency. The call reflects a growing view that the situation requires a wider institutional examination rather than a narrow focus on specific individuals.
At the same time, a separate narrative has emerged around claims that the agency is being sold. Health Minister Alex Katakwe has rejected those reports, describing them as false and maintaining that there is no policy decision to dispose of the institution. The clarification comes amid rising public concern over the future of the agency and its role in the country’s health system.
The overlap between the arrest and the denial has created a layered situation. On one side, investigative processes are raising questions about conduct within the agency. On the other, government is seeking to stabilise public confidence by addressing speculation surrounding the agency’s structure and ownership.
ZAMMSA occupies a central role in the country’s health system, with responsibility for the procurement and distribution of medicines and medical supplies. Its operations directly influence service delivery across hospitals and clinics, making any concerns about its management a matter of national importance.
This centrality has amplified the current reaction. Issues linked to procurement and oversight carry immediate implications for access to essential medicines and the functioning of health facilities. As a result, developments surrounding the agency are being closely watched across both public and private sectors.
The call for a commission of inquiry reflects growing pressure for deeper accountability. Those advocating for such a process argue that a broader investigation would help identify systemic weaknesses, strengthen governance structures and improve transparency. The objective, according to this view, is to ensure that the institution operates effectively and in the public interest.
At the same time, government’s response has focused on maintaining stability within the health sector. By rejecting claims that the agency is being sold, authorities are attempting to prevent confusion and reassure the public that there are no immediate changes to its structure.
The situation is unfolding alongside ongoing health-sector activities, including disease response programmes and the management of medical supplies. These parallel responsibilities underscore the importance of ensuring that operations continue without disruption while governance concerns are addressed.
Two clear tracks have emerged. The first involves the investigative process linked to the arrests, which is expected to determine whether any wrongdoing occurred and what actions may follow. The second involves broader institutional pressure, including calls for transparency, reform and strengthened oversight mechanisms.
How these tracks evolve will shape the direction of the ZAMMSA story in the coming weeks. If attention remains focused on individual cases, the issue may stay within a legal framework. If calls for a wider inquiry gain momentum, it could expand into a broader examination of governance within the health sector.
The outcome carries direct implications for public confidence. Given the agency’s role in ensuring access to medicines and medical supplies, any concerns about its credibility or operations are likely to resonate widely.
For now, the situation remains fluid. Investigations are underway, calls for accountability are increasing and authorities are working to maintain stability within a system that plays a critical role in the country’s healthcare delivery.
